Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment in children news


From To
Vatican makes progress on pushing drug availability for kids with HIV

An initiative to identify and properly treat children living with HIV has gained new momentum as international organizations and pharmaceutical companies respond to a Vatican push to look past profit to doing the right thing.

10 August 2018
Crux: Covering all things Catholic
Pfizer and GSK's HIV/AIDS division, ViiV, prevents children with HIV from getting needed medicine

Despite ViiV pledging in November 2017 that it would expedite the availability of paediatric dolutegravir formulations where these are most critically needed, and despite repeated appeals from MSF and others, almost 18 months after paediatric formulations of dolutegravir were approved for use by the European Medicines Agency, the corporation has started the registration process in only three sub-Saharan African countries

23 July 2018
Médecins Sans Frontières (MSF) International
More than half of children living with HIV still without treatment in high burden, PEPFAR-supported southern African countries

Data across 20 countries receiving PEPFAR support showed 56 percent of children living with HIV under the age of 15 — an estimated 750,000 children — are not receiving the life-saving treatment that also prevents transmission of the virus.

18 May 2018
Science Speaks
What are the outcomes for adults who were born with HIV?

Among people who were born with HIV and have now transitioned to adult care at St Mary’s hospital in London, 80% have an undetectable viral load,

25 April 2018
Roger Pebody
UK Adolescents with Perinatally-Acquired HIV Are Not at Increased Risk of Anxiety, Depression

Adolescents and Adults Living with Perinatal HIV (AALPHI) is an ongoing study in the United Kingdom that follows a cohort of young people with perinatally-acquired HIV (PHIV) and a control group of HIV-affected youth, who have a parent, sibling, or other household member living with HIV.

24 March 2018
MD Magazine
Very early treatment in children limits the HIV reservoir

Very early HIV treatment in infants is feasible and safe and leads to a small reservoir of infected cells, two studies from Botswana and Thailand

13 March 2018
Keith Alcorn
HIV-positive children in resource-limited settings can achieve good virological outcomes without routine viral load or CD4 cell count monitoring

HIV-positive children can achieve good virological outcomes without routine monitoring of CD4 cell count or viral load, investigators report in PLOS Medicine. The research was

27 November 2017
Michael Carter
HIV drug resistance found in more than half of young children in Africa

Approximately 54% of young children with HIV surveyed in Africa had resistance to one or more antiretroviral drugs, according to recent data.

24 August 2017
What can science learn from a child who has controlled HIV without drugs for more than 8 years?

An HIV-infected child in South Africa who is controlling the virus without antiretroviral (ARV) drugs has reinvigorated the push to find ways to allow people to control the virus for prolonged periods without treatment.

27 July 2017
South African child has controlled HIV off treatment for 8.5 years

A nine-year-old South African child who was diagnosed with HIV infection at one month of age and received HIV treatment for 40 weeks during infancy has suppressed the virus

24 July 2017
Keith Alcorn
← First12345...22Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.